RECRUITINGOBSERVATIONAL
Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
About This Trial
Patients with ssc-ild receiving double immunosuppression with or without anti fibrotic tratment
Who May Be Eligible (Plain English)
Who May Qualify:ild-ssc with double immunosuppression
\-
Who Should NOT Join This Trial:
- ssc without ild
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:ild-ssc with double immunosuppression
\-
Exclusion Criteria:
* ssc without ild
Treatments Being Tested
DRUG
Antifibrotic drugs (nidanib or pirfenidone)
Ssc - ild
DRUG
MMF Immunosuppression
we will compare patients with SSc-ILD taking RTX and mmf and patients that are taking RTX,mmf and nintedanib
Locations (1)
University of patras
Pátrai, Greece